We use cookies to help you navigate efficiently and perform certain functions. You will find detailed information about all cookies under each consent category below.
The cookies that are categorized as "Necessary" are stored on your browser as they are essential for enabling the basic functionalities of the site. ...
Necessary cookies are required to enable the basic features of this site, such as providing secure log-in or adjusting your consent preferences. These cookies do not store any personally identifiable data.
Functional cookies help perform certain functionalities like sharing the content of the website on social media platforms, collecting feedback, and other third-party features.
Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics such as the number of visitors, bounce rate, traffic source, etc.
Performance cookies are used to understand and analyze the key performance indexes of the website which helps in delivering a better user experience for the visitors.
Advertisement cookies are used to provide visitors with customized advertisements based on the pages you visited previously and to analyze the effectiveness of the ad campaigns.
Weight loss, diarrhea, decreased appetite, occasional weakness. Glucose checks have been consistently in the low 60s. HCT over 60%, ALT 299, AST 141, BG 61. Recheck BG 64.
Weight loss, diarrhea, decreased appetite, occasional weakness. Glucose checks have been consistently in the low 60s. HCT over 60%, ALT 299, AST 141, BG 61. Recheck BG 64.
Ultrasound-guided FNA of the spleen and lymph nodes is recommended. The 0.74 cm hypoechoic nodule on the left limb of the pancreas may represent insulinoma versus distorted lymph node as they cannot be differentiated one from the other. FNA would be appropriate upon the left pancreatic nodule to distinguish insulinoma from the lymph node as well as FNA of the spleen and accessible mesenteric lymph nodes. The free fluid is likely owing to lymphatic obstruction in this patient. There is concern for lymphoma +/- insulinoma.
So far the patient is doing well clinically except for loose stool. The patient was started on prednisolone and oncology consult is being considered as an option.
Followup: Olive did well on prednisolone 1 mg q 12 hours and metronidazole 10 mg q 12 hours, was eating and playing. She started to become very weak with decreased appetite daily the first week of June. Her owners elected humane euthanasia for her on June 4, while she still had her naturally good spirit. Olive lived happily until about 5 weeks after her initial diagnosis.
Following the ultrasound report, FNAs of the spleen and pancreatic nodule were performed. Cytology of both sites indicated high suspicion for histiocytic sarcoma in the spleen (95% confidence) and the pancreatic lesion (80% confidence). Biopsy recommended for confirmation.
Spleen: The spleen revealed an expansive target type nodule that measured 1.8 cm at the cranial pole. The spleen was otherwise enlarged with scalloping contour with free fluid.
Pancreas: The left limb of the pancreas revealed heterogenous parenchymal changes with a hypoechoic nodule or overlying lymph node measuring 0.74 cm.
Gastrointestinal: The gastrointestinal tract revealed diffuse, hyperechoic fogging or overlay throughout the small intestine as well as areas of mucosal striations and speckling. This striation + fogging effect appeared to exclusively affect the mucosal layer with the submucosa, muscularis and serosa left in-act. Reactive mesentery was present associated with the serosa indicative of active inflammation. This is most consistent with protein losing enteropathy/lymphangectasia. Full thickness biopsies or endoscopic guided biopsies would be ideal to confirm. A cluster of mesenteric lymph nodes with distorted architecture was noted. The largest of which measured 2.04 x 1.02 cm.
Free Abdomen: Minor areas of free fluid was present.
